| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 73 | 2021 | 1025 | 6.790 |
Why?
|
| Heart, Artificial | 21 | 2021 | 69 | 5.440 |
Why?
|
| Heart Failure | 48 | 2021 | 2297 | 3.150 |
Why?
|
| Hemodynamics | 27 | 2021 | 849 | 2.700 |
Why?
|
| Models, Cardiovascular | 14 | 2020 | 185 | 2.680 |
Why?
|
| Equipment Design | 17 | 2020 | 599 | 1.870 |
Why?
|
| Coronary Artery Bypass | 21 | 2015 | 514 | 1.850 |
Why?
|
| Heart Ventricles | 19 | 2021 | 769 | 1.750 |
Why?
|
| Pericardium | 5 | 2021 | 83 | 1.510 |
Why?
|
| Prosthesis Implantation | 12 | 2019 | 141 | 1.500 |
Why?
|
| Aortic Valve | 6 | 2015 | 440 | 1.440 |
Why?
|
| Heart Valve Prosthesis | 7 | 2012 | 298 | 1.430 |
Why?
|
| Prosthesis Design | 26 | 2019 | 681 | 1.400 |
Why?
|
| Ventricular Function, Left | 13 | 2020 | 508 | 1.310 |
Why?
|
| Cardiac Surgical Procedures | 13 | 2021 | 1119 | 1.290 |
Why?
|
| Heart Atria | 7 | 2021 | 316 | 1.280 |
Why?
|
| Device Removal | 13 | 2021 | 221 | 1.240 |
Why?
|
| Pulsatile Flow | 13 | 2018 | 128 | 1.220 |
Why?
|
| Heart Transplantation | 18 | 2019 | 860 | 1.220 |
Why?
|
| Heart Valve Prosthesis Implantation | 8 | 2019 | 435 | 1.210 |
Why?
|
| Aortic Valve Insufficiency | 6 | 2019 | 141 | 1.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 12 | 2024 | 200 | 0.910 |
Why?
|
| Coronary Disease | 9 | 2005 | 675 | 0.910 |
Why?
|
| Cardiomyopathy, Dilated | 3 | 2017 | 213 | 0.840 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2024 | 57 | 0.820 |
Why?
|
| Sternum | 5 | 2010 | 54 | 0.820 |
Why?
|
| Blood Circulation | 3 | 2020 | 21 | 0.760 |
Why?
|
| Cardiac Valve Annuloplasty | 2 | 2012 | 9 | 0.750 |
Why?
|
| Cattle | 14 | 2021 | 569 | 0.730 |
Why?
|
| Abscess | 2 | 2021 | 137 | 0.720 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2007 | 160 | 0.700 |
Why?
|
| Assisted Circulation | 3 | 2015 | 36 | 0.680 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 7 | 2010 | 26 | 0.660 |
Why?
|
| Coronary Circulation | 7 | 2011 | 215 | 0.620 |
Why?
|
| Anastomosis, Surgical | 4 | 2015 | 170 | 0.610 |
Why?
|
| Ventricular Function, Right | 4 | 2018 | 111 | 0.590 |
Why?
|
| Cardiopulmonary Bypass | 9 | 2017 | 355 | 0.570 |
Why?
|
| Humans | 105 | 2021 | 125085 | 0.560 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2017 | 42 | 0.550 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2019 | 369 | 0.540 |
Why?
|
| Multiple Organ Failure | 3 | 2012 | 141 | 0.530 |
Why?
|
| Myocardial Revascularization | 3 | 2010 | 102 | 0.520 |
Why?
|
| Prosthesis-Related Infections | 4 | 2019 | 179 | 0.520 |
Why?
|
| Fluoroscopy | 2 | 2021 | 91 | 0.520 |
Why?
|
| Treatment Outcome | 38 | 2021 | 12388 | 0.520 |
Why?
|
| Sheep | 13 | 2017 | 220 | 0.510 |
Why?
|
| Heart Diseases | 1 | 2021 | 493 | 0.510 |
Why?
|
| Sternotomy | 2 | 2013 | 42 | 0.510 |
Why?
|
| Postoperative Complications | 16 | 2018 | 3071 | 0.500 |
Why?
|
| Swine | 11 | 2024 | 1207 | 0.490 |
Why?
|
| Middle Aged | 51 | 2019 | 26919 | 0.490 |
Why?
|
| Ulnar Artery | 1 | 2015 | 5 | 0.480 |
Why?
|
| Renal Dialysis | 3 | 2015 | 854 | 0.480 |
Why?
|
| Animals | 42 | 2024 | 34219 | 0.480 |
Why?
|
| Vena Cava, Inferior | 2 | 2017 | 103 | 0.480 |
Why?
|
| Veins | 1 | 2015 | 107 | 0.460 |
Why?
|
| Angioplasty | 1 | 2015 | 89 | 0.460 |
Why?
|
| Suture Techniques | 5 | 2015 | 195 | 0.450 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 5174 | 0.450 |
Why?
|
| Mitral Valve | 3 | 2006 | 249 | 0.430 |
Why?
|
| Stents | 3 | 2011 | 887 | 0.430 |
Why?
|
| Coronary Vessels | 6 | 2008 | 555 | 0.430 |
Why?
|
| Models, Animal | 7 | 2014 | 463 | 0.420 |
Why?
|
| Graft Rejection | 2 | 2015 | 588 | 0.420 |
Why?
|
| Amiodarone | 1 | 2013 | 45 | 0.420 |
Why?
|
| Male | 64 | 2021 | 61465 | 0.420 |
Why?
|
| Blood Pressure | 10 | 2018 | 1369 | 0.420 |
Why?
|
| Cardiotonic Agents | 1 | 2014 | 139 | 0.420 |
Why?
|
| Time Factors | 19 | 2018 | 6327 | 0.410 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2008 | 180 | 0.410 |
Why?
|
| Bioprosthesis | 2 | 2010 | 111 | 0.390 |
Why?
|
| Cardiomyopathies | 3 | 2019 | 500 | 0.360 |
Why?
|
| Robotics | 3 | 2010 | 108 | 0.360 |
Why?
|
| Amyloidosis | 1 | 2012 | 72 | 0.350 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2010 | 41 | 0.340 |
Why?
|
| Reoperation | 11 | 2010 | 833 | 0.340 |
Why?
|
| Aortic Rupture | 1 | 2010 | 122 | 0.310 |
Why?
|
| Aneurysm, False | 1 | 2010 | 103 | 0.310 |
Why?
|
| Coronary Artery Disease | 3 | 2010 | 799 | 0.310 |
Why?
|
| Thoracotomy | 7 | 2012 | 111 | 0.290 |
Why?
|
| Intraoperative Care | 2 | 2016 | 105 | 0.290 |
Why?
|
| Shock, Cardiogenic | 5 | 2011 | 192 | 0.290 |
Why?
|
| Aorta | 5 | 2017 | 549 | 0.280 |
Why?
|
| Aged | 30 | 2019 | 19859 | 0.280 |
Why?
|
| Recovery of Function | 5 | 2019 | 445 | 0.270 |
Why?
|
| Atrial Fibrillation | 2 | 2008 | 660 | 0.270 |
Why?
|
| Prosthesis Failure | 5 | 2017 | 158 | 0.260 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2007 | 74 | 0.260 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 62 | 0.260 |
Why?
|
| Adult | 29 | 2021 | 29628 | 0.250 |
Why?
|
| Vascular Resistance | 5 | 2014 | 189 | 0.250 |
Why?
|
| Female | 46 | 2020 | 66744 | 0.250 |
Why?
|
| Cardiac Catheterization | 4 | 2013 | 634 | 0.240 |
Why?
|
| Equipment Failure | 3 | 2017 | 121 | 0.240 |
Why?
|
| Point-of-Care Systems | 1 | 2007 | 174 | 0.230 |
Why?
|
| Severity of Illness Index | 9 | 2014 | 2905 | 0.230 |
Why?
|
| Length of Stay | 6 | 2015 | 1308 | 0.220 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 4392 | 0.220 |
Why?
|
| Aorta, Thoracic | 2 | 2010 | 533 | 0.210 |
Why?
|
| Retrospective Studies | 19 | 2019 | 16326 | 0.210 |
Why?
|
| Ventricular Function | 3 | 2017 | 90 | 0.210 |
Why?
|
| Thoracic Arteries | 1 | 2003 | 5 | 0.210 |
Why?
|
| History, 20th Century | 2 | 2015 | 382 | 0.200 |
Why?
|
| Hemorheology | 2 | 2015 | 25 | 0.200 |
Why?
|
| Blood Loss, Surgical | 3 | 2015 | 153 | 0.200 |
Why?
|
| Poloxamer | 3 | 2006 | 12 | 0.200 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 669 | 0.200 |
Why?
|
| Epigastric Arteries | 2 | 1999 | 7 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 214 | 0.190 |
Why?
|
| Heart | 3 | 2013 | 729 | 0.190 |
Why?
|
| Radiography, Interventional | 2 | 2007 | 87 | 0.190 |
Why?
|
| Electrocardiography | 5 | 2017 | 977 | 0.180 |
Why?
|
| Surgical Flaps | 1 | 2003 | 203 | 0.180 |
Why?
|
| Biocompatible Materials | 2 | 2015 | 118 | 0.180 |
Why?
|
| Pulmonary Circulation | 2 | 2020 | 121 | 0.180 |
Why?
|
| Stomach | 1 | 2003 | 270 | 0.180 |
Why?
|
| Myocardial Ischemia | 2 | 2003 | 344 | 0.180 |
Why?
|
| Materials Testing | 4 | 2019 | 72 | 0.180 |
Why?
|
| Echocardiography | 6 | 2019 | 1051 | 0.170 |
Why?
|
| Feasibility Studies | 7 | 2021 | 762 | 0.170 |
Why?
|
| Wound Healing | 2 | 2018 | 460 | 0.170 |
Why?
|
| Cardiac Output | 3 | 2011 | 171 | 0.160 |
Why?
|
| Endoscopes | 1 | 1999 | 20 | 0.160 |
Why?
|
| Jugular Veins | 2 | 2017 | 77 | 0.160 |
Why?
|
| Polytetrafluoroethylene | 2 | 2011 | 83 | 0.150 |
Why?
|
| Lung | 3 | 2024 | 1498 | 0.150 |
Why?
|
| Vaginal Diseases | 1 | 2018 | 17 | 0.150 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2010 | 101 | 0.150 |
Why?
|
| Subclavian Vein | 1 | 2017 | 22 | 0.140 |
Why?
|
| Printing, Three-Dimensional | 1 | 2018 | 69 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2015 | 1054 | 0.140 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2019 | 43 | 0.140 |
Why?
|
| Video Recording | 1 | 1999 | 183 | 0.140 |
Why?
|
| Magnetics | 1 | 2017 | 41 | 0.140 |
Why?
|
| Oxygen Consumption | 3 | 2014 | 305 | 0.140 |
Why?
|
| Femoral Vein | 1 | 2017 | 51 | 0.140 |
Why?
|
| Ventricular Fibrillation | 1 | 2017 | 51 | 0.140 |
Why?
|
| Intensive Care Units | 2 | 2008 | 491 | 0.140 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2017 | 102 | 0.140 |
Why?
|
| Mammary Arteries | 3 | 2006 | 29 | 0.140 |
Why?
|
| Systole | 1 | 2017 | 200 | 0.140 |
Why?
|
| Vagina | 1 | 2018 | 185 | 0.140 |
Why?
|
| Microcirculation | 2 | 2016 | 95 | 0.140 |
Why?
|
| Diastole | 1 | 2017 | 174 | 0.130 |
Why?
|
| Cardiology | 2 | 2009 | 505 | 0.130 |
Why?
|
| Endothelium, Vascular | 4 | 2015 | 527 | 0.130 |
Why?
|
| Anesthesia | 1 | 1999 | 207 | 0.130 |
Why?
|
| Survival Rate | 5 | 2019 | 2061 | 0.130 |
Why?
|
| Pressure | 1 | 2016 | 131 | 0.130 |
Why?
|
| Pilot Projects | 4 | 2018 | 1398 | 0.130 |
Why?
|
| Epicardial Mapping | 1 | 2015 | 2 | 0.130 |
Why?
|
| Patient Readmission | 1 | 1999 | 385 | 0.130 |
Why?
|
| Transplantation, Heterotopic | 2 | 2005 | 29 | 0.130 |
Why?
|
| Myocarditis | 1 | 2017 | 129 | 0.120 |
Why?
|
| Heart Valve Diseases | 2 | 2009 | 172 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2017 | 101 | 0.120 |
Why?
|
| Feedback | 2 | 2014 | 164 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2016 | 40 | 0.120 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2016 | 55 | 0.120 |
Why?
|
| Hemostasis, Surgical | 2 | 2024 | 37 | 0.120 |
Why?
|
| Blood Flow Velocity | 4 | 2011 | 455 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 76 | 0.120 |
Why?
|
| Tissue Adhesives | 1 | 2015 | 36 | 0.120 |
Why?
|
| Young Adult | 7 | 2019 | 9052 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 442 | 0.110 |
Why?
|
| Risk Assessment | 5 | 2017 | 3456 | 0.110 |
Why?
|
| Diffusion of Innovation | 1 | 2015 | 96 | 0.110 |
Why?
|
| Postoperative Period | 2 | 2008 | 334 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 84 | 0.110 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 52 | 0.110 |
Why?
|
| Inventions | 1 | 2014 | 17 | 0.110 |
Why?
|
| Blood Volume | 1 | 2014 | 81 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2015 | 266 | 0.110 |
Why?
|
| Fatal Outcome | 2 | 2012 | 359 | 0.110 |
Why?
|
| Regional Blood Flow | 2 | 2005 | 209 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2013 | 144 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 192 | 0.110 |
Why?
|
| Risk Factors | 7 | 2019 | 10285 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2015 | 233 | 0.100 |
Why?
|
| Patient Safety | 1 | 2017 | 400 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2013 | 391 | 0.100 |
Why?
|
| Gastric Fistula | 1 | 2012 | 5 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2014 | 151 | 0.100 |
Why?
|
| Software | 2 | 2014 | 683 | 0.100 |
Why?
|
| Intestinal Fistula | 1 | 2012 | 28 | 0.100 |
Why?
|
| Stroke Volume | 5 | 2017 | 488 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2012 | 36 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2013 | 112 | 0.100 |
Why?
|
| Incidence | 4 | 2019 | 3141 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 241 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2014 | 651 | 0.090 |
Why?
|
| Acute Disease | 2 | 2013 | 1110 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2017 | 1195 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2012 | 362 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2014 | 366 | 0.080 |
Why?
|
| Diaphragm | 1 | 2011 | 98 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 1357 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 370 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 2010 | 60 | 0.080 |
Why?
|
| Chest Tubes | 1 | 2009 | 35 | 0.080 |
Why?
|
| Radiography | 1 | 2012 | 821 | 0.080 |
Why?
|
| Optical Fibers | 1 | 2009 | 18 | 0.080 |
Why?
|
| Hydrogen | 1 | 2009 | 41 | 0.080 |
Why?
|
| Tracheotomy | 1 | 2009 | 35 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2009 | 77 | 0.080 |
Why?
|
| Cadherins | 2 | 2015 | 171 | 0.080 |
Why?
|
| Vascular Fistula | 1 | 2009 | 31 | 0.080 |
Why?
|
| Vasodilation | 2 | 2006 | 191 | 0.070 |
Why?
|
| Coronary Stenosis | 2 | 2008 | 78 | 0.070 |
Why?
|
| Exercise | 1 | 2014 | 812 | 0.070 |
Why?
|
| Cardiac Output, High | 1 | 2007 | 2 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2015 | 432 | 0.070 |
Why?
|
| Cyanosis | 1 | 2008 | 42 | 0.070 |
Why?
|
| Endocarditis | 1 | 2009 | 106 | 0.070 |
Why?
|
| Critical Illness | 2 | 2017 | 601 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 321 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2012 | 940 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2009 | 224 | 0.070 |
Why?
|
| Adolescent | 6 | 2019 | 19349 | 0.070 |
Why?
|
| Neurilemmoma | 1 | 2007 | 44 | 0.070 |
Why?
|
| Consciousness | 1 | 2007 | 49 | 0.070 |
Why?
|
| Surface-Active Agents | 1 | 2006 | 33 | 0.070 |
Why?
|
| Arteriovenous Fistula | 1 | 2007 | 56 | 0.070 |
Why?
|
| Pulse | 1 | 2006 | 29 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2009 | 465 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 171 | 0.060 |
Why?
|
| Heart Neoplasms | 1 | 2007 | 101 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2006 | 39 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 131 | 0.060 |
Why?
|
| Hemostatic Techniques | 1 | 2005 | 32 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 589 | 0.060 |
Why?
|
| Graft Survival | 1 | 2008 | 535 | 0.060 |
Why?
|
| Exercise Test | 2 | 2021 | 253 | 0.060 |
Why?
|
| Electrosurgery | 1 | 2024 | 16 | 0.060 |
Why?
|
| Heart Rate | 3 | 2015 | 591 | 0.050 |
Why?
|
| Recurrence | 3 | 2015 | 1421 | 0.050 |
Why?
|
| Biomechanical Phenomena | 2 | 2018 | 245 | 0.050 |
Why?
|
| Collateral Circulation | 1 | 2003 | 45 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 41 | 0.050 |
Why?
|
| Myocardial Reperfusion | 1 | 2003 | 73 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 311 | 0.050 |
Why?
|
| Pneumonectomy | 1 | 2024 | 143 | 0.050 |
Why?
|
| Tensile Strength | 1 | 2002 | 40 | 0.050 |
Why?
|
| Dogs | 1 | 2003 | 774 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 6596 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2008 | 4814 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 2054 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2008 | 804 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1436 | 0.050 |
Why?
|
| Texas | 3 | 2015 | 3587 | 0.050 |
Why?
|
| Tachycardia | 1 | 2000 | 70 | 0.040 |
Why?
|
| Magnesium | 1 | 2000 | 123 | 0.040 |
Why?
|
| Equipment Failure Analysis | 2 | 2011 | 85 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 240 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2100 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2017 | 443 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1696 | 0.040 |
Why?
|
| Forecasting | 1 | 2001 | 352 | 0.040 |
Why?
|
| Blood Transfusion | 2 | 2014 | 313 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 17 | 0.040 |
Why?
|
| Thrombosis | 2 | 2007 | 525 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1365 | 0.040 |
Why?
|
| Liver | 1 | 2006 | 1743 | 0.040 |
Why?
|
| Biomedical Engineering | 2 | 2008 | 28 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 61 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2018 | 128 | 0.040 |
Why?
|
| Sex Distribution | 1 | 1999 | 306 | 0.040 |
Why?
|
| Surgical Staplers | 1 | 1997 | 2 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 1999 | 435 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 122 | 0.040 |
Why?
|
| Age Distribution | 1 | 1999 | 417 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2017 | 28 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 1997 | 56 | 0.040 |
Why?
|
| Boston | 1 | 1997 | 109 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 142 | 0.040 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 21 | 0.040 |
Why?
|
| United States | 2 | 2019 | 10913 | 0.040 |
Why?
|
| Treatment Failure | 2 | 2015 | 340 | 0.040 |
Why?
|
| Cicatrix | 1 | 2018 | 124 | 0.030 |
Why?
|
| Miniaturization | 1 | 2017 | 26 | 0.030 |
Why?
|
| Angiography | 1 | 1997 | 215 | 0.030 |
Why?
|
| Punctures | 1 | 2017 | 55 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 1506 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 151 | 0.030 |
Why?
|
| Catheterization | 1 | 2018 | 236 | 0.030 |
Why?
|
| Operative Time | 1 | 2017 | 167 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 979 | 0.030 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 130 | 0.030 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 55 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 1996 | 48 | 0.030 |
Why?
|
| Gels | 2 | 2006 | 69 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 1823 | 0.030 |
Why?
|
| Patient Selection | 2 | 2015 | 699 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2016 | 32 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 199 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2015 | 15 | 0.030 |
Why?
|
| Czech Republic | 1 | 2015 | 11 | 0.030 |
Why?
|
| Coronary Vasospasm | 1 | 2015 | 10 | 0.030 |
Why?
|
| Germany | 1 | 2015 | 65 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 1996 | 115 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 56 | 0.030 |
Why?
|
| Leucine | 1 | 1996 | 310 | 0.030 |
Why?
|
| Gelatin | 1 | 2014 | 17 | 0.030 |
Why?
|
| Edema | 1 | 2015 | 136 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2014 | 101 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 82 | 0.030 |
Why?
|
| Drainage | 1 | 2015 | 259 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 307 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 157 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2015 | 6153 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 522 | 0.030 |
Why?
|
| Neutrophils | 1 | 1996 | 381 | 0.030 |
Why?
|
| Stroke | 2 | 2014 | 986 | 0.030 |
Why?
|
| Logistic Models | 2 | 2014 | 1807 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2014 | 125 | 0.030 |
Why?
|
| Bilirubin | 1 | 2014 | 122 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1236 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2169 | 0.030 |
Why?
|
| Homeostasis | 2 | 2009 | 702 | 0.030 |
Why?
|
| Hospitalization | 1 | 2001 | 1779 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1996 | 463 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 1120 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2012 | 77 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 260 | 0.020 |
Why?
|
| Biomarkers | 2 | 2014 | 3081 | 0.020 |
Why?
|
| Postoperative Care | 2 | 2008 | 300 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 899 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2013 | 99 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 383 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2016 | 322 | 0.020 |
Why?
|
| Myocardium | 1 | 2017 | 1015 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2016 | 542 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 873 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1255 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2015 | 353 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 2010 | 26 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 593 | 0.020 |
Why?
|
| Viridans Streptococci | 1 | 2009 | 8 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 946 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1241 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2008 | 28 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 75 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2008 | 58 | 0.020 |
Why?
|
| Debridement | 1 | 2009 | 89 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2009 | 285 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2009 | 85 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2008 | 65 | 0.020 |
Why?
|
| Mathematics | 1 | 2008 | 96 | 0.020 |
Why?
|
| Hormones | 1 | 2009 | 186 | 0.020 |
Why?
|
| Drug-Eluting Stents | 1 | 2008 | 64 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2007 | 21 | 0.020 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2006 | 15 | 0.020 |
Why?
|
| Subclavian Artery | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 142 | 0.020 |
Why?
|
| Hematocrit | 1 | 2007 | 111 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 270 | 0.020 |
Why?
|
| Centrifugation | 1 | 2005 | 25 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2006 | 168 | 0.010 |
Why?
|
| Decision Making | 1 | 2009 | 656 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 666 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2008 | 438 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2008 | 1025 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 2817 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 1039 | 0.010 |
Why?
|
| Surgical Equipment | 1 | 1999 | 4 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2890 | 0.010 |
Why?
|
| Heart Arrest, Induced | 1 | 1999 | 74 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2001 | 355 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 1997 | 3298 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1999 | 118 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 244 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 1998 | 133 | 0.010 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 1997 | 43 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2426 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 1996 | 6 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1996 | 17 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1996 | 11 | 0.010 |
Why?
|
| Colforsin | 1 | 1996 | 50 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1996 | 38 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1996 | 47 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1996 | 106 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 4637 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1996 | 20 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 83 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1997 | 202 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1996 | 68 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1996 | 94 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 82 | 0.010 |
Why?
|
| Fees and Charges | 1 | 1995 | 10 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1996 | 628 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1996 | 344 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 204 | 0.010 |
Why?
|
| Disease Progression | 1 | 1997 | 2062 | 0.010 |
Why?
|
| Obesity | 1 | 1997 | 2247 | 0.000 |
Why?
|